+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Correlated cholinomimetic-stimulated beta-endorphin and prolactin release in humans



Correlated cholinomimetic-stimulated beta-endorphin and prolactin release in humans



Peptides 3(3): 319-322



Previous studies, both in animals and humans, have demonstrated that the intravenous or intraventricular administration of endogenous opioids and opiates produce dose dependent increases in plasma concentrations of prolactin. Notably, in humans, intravenous infusion of centrally active cholinomimetic drugs, such as physostigmine or arecoline, may produce significant increases in plasma concentrations of prolactin and beta-endorphin immunoreactivity. In three separate studies, conducted collaboratively between the National Institute of Mental Health and the University of California at San Diego, physostigmine and arecoline associated increases in plasma concentrations of beta-endorphin immunoreactivity were highly correlated with increases in plasma prolactin concentrations. These results are of interest because centrally active cholinomimetic drugs have been variously reported either to have no effect, to increase, or to inhibit anterior pituitary prolactin release. We propose that cholinergic stimulation of hypothalamic beta-endorphin may represent an interesting example of peptidergic modulation of primary neurochemical effects on hypothalamic-pituitary hormonal regulation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 042687264

Download citation: RISBibTeXText

PMID: 6289276

DOI: 10.1016/0196-9781(82)90093-6


Related references

Cholinomimetic-induced co-release of prolactin and beta-endorphin in man. Psychopharmacology Bulletin 18(4): 21-25, 1982

Time-dependent changes in beta-endorphin-stimulated prolactin release during pregnancy. Neuroendocrinology 56(2): 246-254, 1992

Beta-endorphin-stimulated prolactin release in lactating rats following alcohol administration. Alcohol 11(3): 269-272, 1994

Isoproterenol-stimulated release of beta-endorphin and related peptides from the rat pituitary neurointermediate lobe in vitro: evidence for preferential release of certain molecular forms of beta-endorphin. Neuropeptides 17(2): 63-74, 1990

Effects of beta-endorphin fragment 6-31 on morphine- and beta-endorphin-induced growth hormone and prolactin release. European Journal of Pharmacology 99(4): 341-343, 1984

The content of beta-endorphin-like immunoreactivity in porcine corpus luteum and the potential roles of progesterone, oxytocin and prolactin in the regulation of beta-endorphin release from luteal cells in vitro. Reproduction in Domestic Animals 36(2): 107-112, 2001

Evidence for an intrinsic cholinomimetic agent interacting with vip and isoproterenol stimulated prolactin and growth hormone release in pituitary cell aggregates. Journal of Endocrinological Investigation 10(Suppl. 3): 85, 1987

Stimulation of prolactin and growth hormone release by intra ventricular injection of methionine enkephalin beta endorphin and endorphin analogs in the rat. Lederis, K. L. Veale (ed.). Current Studies Of Hypothalamic Function: Basel, Switzerland; New York, N.y., Usa. ISBN 3-8055-2860-4: 151-163, 1978

Effects of beta endorphin fragment 6 31 on morphine induced and beta endorphin induced growth hormone and prolactin release. European Journal of Pharmacology 99(4): 341-344, 1984

Time-Dependent Changes in -Endorphin-Stimulated Prolactin Release during Pregnancy. Neuroendocrinology 56(2): 246-254, 1992

Biosynthesis and release of beta-endorphin-, N-acetyl beta-endorphin-, beta-endorphin-(1-27)-, and N-acetyl beta-endorphin-(1-27)-like peptides by rat pituitary neurointermediate lobe: beta-endorphin is not further processed by anterior lobe. Journal of Neuroscience 1(6): 585-595, 1981

Effects of Pituitary Beta-Endorphin Secretagogues on the Concentration of Beta-Endorphin in Rat Cerebrospinal Fluid: Evidence for a Role of Vasopressin in the Regulation of Brain Beta-Endorphin Release. Neuroendocrinology 51(1): 104-110, 1990

Effects of pituitary beta-endorphin secretagogues on the concentration of beta-endorphin in rat cerebrospinal fluid: evidence for a role of vasopressin in the regulation of brain beta-endorphin release. Neuroendocrinology 51(1): 104-110, 1990

Possible delta receptor mediation of the effect of beta-endorphin on luteinizing hormone (LH) release, but not on prolactin (PRL) release, in the ovariectomized rat. Endocrinology 116(1): 475-477, 1985

Correlative evidence for a role of hypothalamic oxytocin ot and beta endorphin beta ep in suckling induced prolactin prl release. Society for Neuroscience Abstracts 14(1): 74, 1988